The development and reliability of the Recovery Attitude and Treatment Evaluator-Questionnaire I (RAATE-QI).
A reliability study was performed on a new 94-item true-false report instrument called the Recovery Attitude And Treatment Evaluator-Questionnaire I (RAATE-QI). The RAATE-QI consists of five dimensions which assess a patient's status in five clinically relevant areas for making admission assessment, treatment placement/matching and planning decisions, and discharge/follow-up outcome assessments. The five dimensions measure: resistance to treatment (treatment motivation and denial), resistance to continuing care (long-term denial), biomedical acuity, psychiatric/psychological acuity, and social/family environmental support status. Data on 143 inpatients who completed the RAATE-QI from a public sector chemical dependency/dual diagnosis treatment unit demonstrated test-retest reliabilities in the range from .73 to .87, and internal consistency reliabilities in the range from .63 to .78 across the five dimensions. These preliminary data suggest that the RAATE-QI may be a clinically reliable assessment/placement tool.
Smith
M B
MB
New Standards, Inc., St. Paul, Minnesota 55116, USA.
Hoffmann
N G
NG
Nederhoed
R
R
D000293:Adolescent; D000328:Adult; D000359:Aftercare / Q000523:psychology; D000368:Aged; D000437:Alcoholism / Q000523:psychology / Q000534:rehabilitation*; D002648:Child; D003674:Defense Mechanisms; D017831:Diagnosis, Dual (Psychiatry); D005260:Female; D006801:Humans; D013287:Illicit Drugs; D007389:Internal-External Control; D008297:Male; D008875:Middle Aged; D010043:Outcome and Process Assessment, Health Care; D010343:Patient Admission; D017060:Patient Satisfaction; D010555:Personality Inventory / Q000706:statistics & numerical data*; D011594:Psychometrics; D011619:Psychotropic Drugs; D015203:Reproducibility of Results; D012803:Sick Role; D019966:Substance-Related Disorders / Q000523:psychology / Q000534:rehabilitation*
D013287:Illicit Drugs; D011619:Psychotropic Drugs